Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVEC.L Share News (VEC)

  • There is currently no data for VEC

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director dealings: Skyepharma CFO gets cash injection from Vectura merger

Mon, 20th Jun 2016 13:41

(ShareCast News) - Skyepharma's chief financial officer Andrew Derodra has pocketed a healthy cash injection after the completion of the merger with Vectura.Derodra exercised nil-cost options over 150,000 Skyepharma shares that were a bonus in his long-term incentive plan that vested on completion of the merger on Friday and so were automatically converted into new Vectura shares.Under the merger agreement, shares in Skyepharma are exchanged for ordinary shares of 0.025 pence in Vectura at a ratio of 2.7977405 Vectura shares for each Skyepharma share.Derodra, who is remaining part of the management team of the enlarged group, later on Friday sold all 419,661 of his new Vectura shares in London at an average price of £1.536209 per share, making over £644,000.The combined group will see Derodra led by James Ward-Lilley, Vectura's chief executive officer, in the CEO seat, with Vectura's Trevor Phillips as chief operating officer and Vectura chairman Bruno Angelici also chairman of the enlarged group. Top Director BuysGlobalworth Real Estate Investments Limited (GWI)Director name: Papalekas,Ioannis Amount purchased: 10,000 @ € 5.15Value: € 51,500.00Hikma Pharmaceuticals (HIK)Director name: Darwazah,MazenAmount purchased: 70,000 @ 21.65pValue: £15,155.00Hikma Pharmaceuticals (HIK)Director name: Darwazah,SaidAmount purchased: 70,000 @ 21.65pValue: £15,155.00Hikma Pharmaceuticals (HIK)Director name: Al-Husry,AliAmount purchased: 70,000 @ 21.65pValue: £15,155.00Stilo International (STL)Director name: Ashman,DavidAmount purchased: 200,000 @ 5.63pValue: £11,250.00U And I Group (UAI)Director name: Weiner,MatthewAmount purchased: 20,985 @ 1.85pValue: £388.22Johnson Matthey (JMAT)Director name: MacLeod,RobertAmount purchased: 12 @ 2,889.00pValue: £346.68Johnson Matthey (JMAT)Director name: Walker,JohnAmount purchased: 12 @ 2,889.00pValue: £346.68Top Director SellsVectura Group (VEC)Director name: Derodra,AndrewOption sale: 419,661 @ 153.62pValue: £644,687.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Whitehead,PeterAmount purchased: 20,391 @ 1,201.00pValue: £244,895.91Young & Co's Brewery 'a' Shares (YNGA)Director name: Goodyear,StephenAmount purchased: 15,000 @ 1,201.00pValue: £180,150.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Sligo-Young,TorquilAmount purchased: 8,000 @ 1,201.00pValue: £96,080.00Young & Co's Brewery 'a' Shares (YNGA)Director name: Sligo-Young,TorquilAmount purchased: 2,500 @ 1,201.00pValue: £30,025.00
More News
19 Mar 2021 09:46

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

BROKER RATINGS: Barclays and Goldman Sachs downgrade Hammerson

Read more
18 Mar 2021 10:36

Vectura shares rise on swing to profit, GBP115 million special payout

Vectura shares rise on swing to profit, GBP115 million special payout

Read more
18 Mar 2021 07:43

Royalty income, litigation win see Vectura beat expectations

(Sharecast News) - Vectura reported a 6.9% improvement in its total revenue on Thursday, to £190.6m, driven by development services and a surge in income from royalties.

Read more
11 Mar 2021 16:13

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
5 Mar 2021 12:29

Vectura delays results because of KPMG staff shortage

(Sharecast News) - Vectura delayed the publication of its annual results after KPMG asked for more time to audit the accounts because of a staff shortage caused by Covid-19.

Read more
2 Mar 2021 16:01

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
22 Jan 2021 09:32

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

LONDON BROKER RATINGS SUMMARY: Deutsche Bank Ups British Land, Landsec

Read more
12 Jan 2021 10:13

Vectura Forecasts 2020 Earnings To Top Board Expectations

Vectura Forecasts 2020 Earnings To Top Board Expectations

Read more
12 Jan 2021 08:16

Vectura reports 'strong' operational performance in 2020

(Sharecast News) - Inhaled medicines-focussed pharmaceutical company Vectura Group updated the market on its trading on Tuesday, saying it expected revenue and adjusted EBITDA for 2020 to be ahead of board expectations, following the fourth quarter approval of VR315 (US), or generic 'Advair', alongside Hikma.

Read more
30 Dec 2020 19:10

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

UK EXECUTIVE CHANGE SUMMARY: Nutrition Firm Director Joins Tate & Lyle

Read more
29 Dec 2020 12:04

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Vectura Says Glaxo Will Not Appeal Award In Ellipta Litigation

Read more
29 Dec 2020 10:04

Glaxo not seeking re-hearing in Ellipta litigation, says Vectura

(Sharecast News) - Vectura said on Tuesday that GlaxoSmithKline has not sought to petition the US Court of Appeals for a re-hearing in the companies' ongoing litigation over GSK's Ellipta inhalers.

Read more
18 Dec 2020 17:08

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

LONDON MARKET CLOSE: Stocks Fall As Investors Sweat On Brexit Deal

Read more
18 Dec 2020 12:08

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

LONDON MARKET MIDDAY: FTSE 100 Rises As Crunch Brexit Talks Dent Pound

Read more
18 Dec 2020 10:45

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

UK WINNERS & LOSERS SUMMARY: US Generic Advair Ok Lifts Hikma, Vectura

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.